Not all DTC patients with N positive disease deserve the attribution “high risk”. Contribution of the MSDS trial-Reference-Cited by-同舟云学术

Not all DTC patients with N positive disease deserve the attribution “high risk”. Contribution of the MSDS trial

Author:

Vrachimis Alexis¹,Wenning Christian¹,Gerß Joachim²,Dralle Henning³,Vaez Tabassi Mohammad¹,Schober Otmar¹,Riemann Burkhard¹,

Affiliation:

1. Department of Nuclear Medicine; University Hospital Münster, Albert-Schweitzer-Campus 1; Münster Germany

2. Institute of Biostatistics and Clinical Research; University Hospital Münster, Albert-Schweitzer-Campus 1; Münster Germany

3. Department of General; Visceral and Vascular Surgery; University Hospital, Medical Faculty, University of Halle-Wittenberg; Halle/Saale Germany

Funder

the German Cancer Aid

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference20 articles.

3. MSDS study group: Are “high-risk” patients with differentiated thyroid cancer “healthy patients”?;Riemann;Nuklearmedizin,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献